Skip to main content
padlock icon - secure page this page is secure

Venlafaxine Extended Release (XR) for the Prophylaxis of Migraine and Tension-type Headache: A Retrospective Study in a Clinical Setting

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Objective.—To assess the efficacy of extended-release venlafaxine in the prophylaxis of migraine and chronic tension-type headache.

Background.—Venlafaxine, a structurally novel antidepressant, is a selective serotonin-norepinephrine reuptake inhibitor. This study is the first to test the effects of extended-release venlafaxine on headaches.

Methods.—Patients were evaluated on a retrospective basis. Fifty-six patients with chronic tension-type headache and 114 patients with migraine were prescribed extended-release venlafaxine. Nearly all the study subjects had been resistant to several previous preventive medications. Patients took venlafaxine for an average of 6 months with a median dose of 150 mg (range, 37.5 to 300 mg).

Results.—The mean frequency of headaches in the group with chronic tension-type headache fell from 24.0 to 15.2 per month (P < .0001). The group with migraine showed a reduction from 16.1 to 11.1 headaches per month (P < .0001). The medicine was well tolerated.

Conclusions.—This trial indicates that extended-release venlafaxine has potential in headache prophylaxis based on its efficacy and safety profile. We recommend a double-blind, placebo-controlled study to further assess the role of extended-release venlafaxine in headache prevention.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: antidepressant; chronic tension-type headache; migraine; norepinephrine; serotonin; venlafaxine XR

Document Type: Research Article

Publication date: July 1, 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more